リウマチ性心疾患の世界市場レポート 2025年

リウマチ性心疾患市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.0％で34億4,000万米ドルに成長します。予測期間中の成長は、予防検診プログラムの採用増加、早期発見に対する意識の高まり、発展途上地域におけるヘルスケア投資の増加、遠隔診断のための遠隔医療の拡大、疾病予防に対する政府の取り組みなどに起因すると考えられます。予測期間中に予想される世界の動向には、診断におけるAIの利用拡大、心エコー検査に基づくスクリーニングの拡大、モバイルヘルスソリューションの統合、新規抗炎症療法の開発、世界の疾患撲滅を目指した共同研究などがあります。

溶連菌感染症の有病率の増加は、今後のリウマチ性心疾患市場の成長を牽引すると予想されます。溶連菌感染症は、化膿レンサ球菌（A群レンサ球菌）による細菌感染症で、のどの炎症、痛み、発熱、リンパ節の腫れ、嚥下困難を引き起こします。抗生物質耐性菌の増加により、溶連菌感染症の効果的な治療が難しくなっており、その結果、罹患が長期化し、地域社会での感染率が高くなっています。リウマチ性心疾患は、溶連菌感染症の未治療または再発による長期的な合併症として開発され、重篤な心臓障害を予防するための溶連菌感染症の早期診断と治療の重要性を強調しています。例えば、2023年4月、米国の政府機関である疾病対策予防センター（CDC）は、溶連菌感染症が65歳未満の年間約520万人の外来患者を占めていると報告しました。これらの受診により、毎年280万件の抗生物質が処方されています。そのため、溶連菌感染症の増加はリウマチ性心疾患市場の成長に寄与しています。

リウマチ性心疾患市場の主なプレーヤーは、革新的な治療法や診断ソリューションを開発するために戦略的パートナーシップを採用しています。こうしたパートナーシップは、研究の推進、診断・治療技術の向上、市場範囲の拡大、商品化の迅速化などのために、リソースや専門知識を結集するものです。例えば、2023年7月、スイスを拠点とするNGOである世界心臓連盟（WHF）は、オランダを拠点とする非営利団体であるフィリップス財団と提携し、アジア太平洋（APAC）地域におけるリウマチ性心疾患（RHD）の認知度向上、医療トレーニング、早期発見を目指しました。フィリピンで開始されたこのイニシアチブは、訓練を受けた専門家と高度な診断ツールを医療施設に備えることで、危険にさらされている50万人以上のフィリピンの子どもたちのヘルスケア・アクセスを改善することを目的としています。この協力は、ヘルスケア・インフラを強化し、RHD患者へのタイムリーな介入を確保するという共通のコミットメントを浮き彫りにするものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界リウマチ性心疾患PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のリウマチ性心疾患市場：成長率分析
• 世界のリウマチ性心疾患市場の実績：規模と成長, 2019-2024
• 世界のリウマチ性心疾患市場の予測：規模と成長, 2024-2029, 2034F
• 世界リウマチ性心疾患総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のリウマチ性心疾患市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バルブ
• 心筋炎
• 心膜炎
• 世界のリウマチ性心疾患市場：年齢層別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小児（0～14歳）
• 青年期（15～24歳）
• 成人（25～64歳）
• 高齢者（65歳以上）
• 世界のリウマチ性心疾患市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断センター
• 研究センター
• 世界のリウマチ性心疾患市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 直接販売
• 世界のリウマチ性心疾患市場、バルブのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 僧帽弁疾患
• 大動脈弁疾患
• 三尖弁疾患
• 肺弁疾患
• 世界のリウマチ性心疾患市場心筋炎の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 急性心筋炎
• 慢性心筋炎
• 劇症心筋炎
• 世界のリウマチ性心疾患市場、心膜炎の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 急性心膜炎
• 慢性心膜炎
• 収縮性心膜炎
• 滲出性心膜炎

第7章 地域別・国別分析

• 世界のリウマチ性心疾患市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のリウマチ性心疾患市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• リウマチ性心疾患市場：競合情勢
• リウマチ性心疾患市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• Abbott Laboratories
• GlaxoSmithKline plc（GSK）
• Medtronic plc
• Siemens Healthineers AG
• Fresenius Medical Care AG & Co. KGaA
• Becton Dickinson and Company（BD）
• GE HealthCare Technologies Inc.
• Mayo Clinic
• Boston Scientific Corporation
• Johns Hopkins Medicine
• Terumo Corporation
• The Mount Sinai Health System Inc.
• Apollo Hospitals Enterprise Limited
• Fortis Healthcare Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• リウマチ性心疾患市場2029：新たな機会を提供する国
• リウマチ性心疾患市場2029：新たな機会を提供するセグメント
• リウマチ性心疾患市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Rheumatic heart disease (RHD) is a chronic condition caused by permanent damage to the heart valves due to rheumatic fever, an inflammatory disease that results from untreated or inadequately treated streptococcal throat infections. The immune response triggered by the infection causes inflammation and scarring of the heart valves, impairing their function and potentially leading to heart failure, arrhythmias, or other complications.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary types of rheumatic heart disease include valve-related disease, myocarditis, and pericarditis. Valve-related rheumatic heart disease occurs when rheumatic fever damages the heart valves, leading to impaired blood flow and complications such as stenosis or regurgitation. Affected age groups include pediatric, adolescent, adult, and geriatric populations. Rheumatic heart disease is treated and managed across various healthcare settings, such as hospitals, diagnostic centers, and research institutions. The distribution channels for related medications include hospital pharmacies, retail pharmacies, online pharmacies, and direct sales.

The rheumatic heart disease market research report is one of a series of new reports from The Business Research Company that provides rheumatic heart disease market statistics, including the rheumatic heart disease industry global market size, regional shares, competitors with the rheumatic heart disease market share, detailed rheumatic heart disease market segments, market trends, and opportunities, and any further data you may need to thrive in the rheumatic heart disease industry. This rheumatic heart disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The rheumatic heart disease market size has grown strongly in recent years. It will grow from$2.56 billion in 2024 to $2.72 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth during the historic period can be attributed to the prevalence of untreated strep infections, limited access to healthcare in low-income regions, a lack of awareness about rheumatic heart disease, delayed diagnosis and treatment, and insufficient vaccination programs.

The rheumatic heart disease market size is expected to see strong growth in the next few years. It will grow to$3.44 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth during the forecast period can be attributed to the increasing adoption of preventive screening programs, growing awareness about early detection, rising healthcare investments in developing regions, the expansion of telemedicine for remote diagnosis, and government initiatives for disease prevention. Key trends anticipated in the forecast period include the growing use of AI in diagnostics, the expansion of echocardiography-based screening, the integration of mobile health solutions, the development of novel anti-inflammatory therapies, and collaborations aimed at global disease eradication.

The growing prevalence of strep throat is expected to drive the growth of the rheumatic heart disease market in the future. Strep throat is a bacterial infection caused by Streptococcus pyogenes (group A streptococcus), leading to throat inflammation, pain, fever, swollen lymph nodes, and difficulty swallowing. The rise in antibiotic resistance is making streptococcal infections harder to treat effectively, resulting in prolonged illnesses and higher transmission rates in communities. Rheumatic heart disease develops as a long-term complication of untreated or recurrent strep throat infections, emphasizing the importance of early diagnosis and treatment of streptococcal infections to prevent severe heart damage. For example, in April 2023, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported that strep throat accounts for approximately 5.2 million outpatient visits annually among individuals under 65 years old. These visits lead to 2.8 million antibiotic prescriptions each year. Therefore, the increasing prevalence of strep throat is contributing to the growth of the rheumatic heart disease market.

Key players in the rheumatic heart disease market are adopting strategic partnerships to develop innovative treatments and diagnostic solutions. These partnerships combine resources and expertise to advance research, improve diagnostic and therapeutic technologies, expand market reach, and expedite commercialization. For instance, in July 2023, the World Heart Federation (WHF), a Switzerland-based NGO, joined forces with the Philips Foundation, a Netherlands-based nonprofit, to increase awareness, medical training, and early detection of rheumatic heart disease (RHD) in the Asia-Pacific (APAC) region. Launched in the Philippines, this initiative aims to improve healthcare access for over half a million Filipino children at risk by equipping healthcare facilities with trained professionals and advanced diagnostic tools. This collaboration highlights a shared commitment to strengthening healthcare infrastructure and ensuring timely intervention for RHD patients.

In February 2025, Light AI Inc., a healthcare technology company based in Canada, partnered with MrBeast Industries to support global health initiatives. The collaboration focuses on providing AI-powered Strep A tests across Africa, enabling early detection and prevention of the disease to reduce the risk of complications such as rheumatic heart disease. MrBeast Industries is a US-based media and entertainment company known for its digital content creation.

Major players in the rheumatic heart disease market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, Abbott Laboratories, GlaxoSmithKline plc (GSK), Medtronic plc, Siemens Healthineers AG, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company (BD), GE HealthCare Technologies Inc., Mayo Clinic, Boston Scientific Corporation, Johns Hopkins Medicine, Terumo Corporation, The Mount Sinai Health System Inc., Apollo Hospitals Enterprise Limited, Fortis Healthcare Limited, and Medanta.

North America was the largest region in the rheumatic heart disease market in 2024. The regions covered in rheumatic heart disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the rheumatic heart disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The rheumatic heart disease market consists of revenues earned by entities by providing services such as surgical treatments, diagnostic tests, preventive care services, and pediatric care services. The market value includes the value of related goods sold by the service provider or included within the service offering. The rheumatic heart disease market also includes sales of antibiotics, anti-inflammatory medications, diuretics, beta-blockers, and ACE inhibitors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Rheumatic Heart Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rheumatic heart disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rheumatic heart disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The rheumatic heart disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Valve; Myocarditis; Pericarditis
• 2) By Age Group: Pediatric; Adolescent; Adult; Geriatric
• 3) By Application: Hospital; Diagnostic Centre; Research Centre
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Direct Sales
• Subsegments:
• 1) By Valve: Mitral Valve Disease; Aortic Valve Disease; Tricuspid Valve Disease; Pulmonary Valve Disease
• 2) By Myocarditis: Acute Myocarditis; Chronic Myocarditis; Fulminant Myocarditis
• 3) By Pericarditis: Acute Pericarditis; Chronic Pericarditis; Constrictive Pericarditis; Effusive Pericarditis
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Bayer AG; Sanofi S.A.; AstraZeneca plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Rheumatic Heart Disease Market Characteristics

3. Rheumatic Heart Disease Market Trends And Strategies

4. Rheumatic Heart Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Rheumatic Heart Disease Growth Analysis And Strategic Analysis Framework

• 5.1. Global Rheumatic Heart Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Rheumatic Heart Disease Market Growth Rate Analysis
• 5.4. Global Rheumatic Heart Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Rheumatic Heart Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Rheumatic Heart Disease Total Addressable Market (TAM)

6. Rheumatic Heart Disease Market Segmentation

• 6.1. Global Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Valve
• Myocarditis
• Pericarditis
• 6.2. Global Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pediatric (0-14 Years)
• Adolescent (15-24 Years)
• Adult (25-64 Years)
• Geriatric (65 Years And Above)
• 6.3. Global Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Diagnostic Centre
• Research Centre
• 6.4. Global Rheumatic Heart Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Direct Sales
• 6.5. Global Rheumatic Heart Disease Market, Sub-Segmentation Of Valve, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mitral Valve Disease
• Aortic Valve Disease
• Tricuspid Valve Disease
• Pulmonary Valve Disease
• 6.6. Global Rheumatic Heart Disease Market, Sub-Segmentation Of Myocarditis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Myocarditis
• Chronic Myocarditis
• Fulminant Myocarditis
• 6.7. Global Rheumatic Heart Disease Market, Sub-Segmentation Of Pericarditis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Pericarditis
• Chronic Pericarditis
• Constrictive Pericarditis
• Effusive Pericarditis

7. Rheumatic Heart Disease Market Regional And Country Analysis

• 7.1. Global Rheumatic Heart Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Rheumatic Heart Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Rheumatic Heart Disease Market

• 8.1. Asia-Pacific Rheumatic Heart Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Rheumatic Heart Disease Market

• 9.1. China Rheumatic Heart Disease Market Overview
• 9.2. China Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Rheumatic Heart Disease Market

• 10.1. India Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Rheumatic Heart Disease Market

• 11.1. Japan Rheumatic Heart Disease Market Overview
• 11.2. Japan Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Rheumatic Heart Disease Market

• 12.1. Australia Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Rheumatic Heart Disease Market

• 13.1. Indonesia Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Rheumatic Heart Disease Market

• 14.1. South Korea Rheumatic Heart Disease Market Overview
• 14.2. South Korea Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Rheumatic Heart Disease Market

• 15.1. Western Europe Rheumatic Heart Disease Market Overview
• 15.2. Western Europe Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Rheumatic Heart Disease Market

• 16.1. UK Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Rheumatic Heart Disease Market

• 17.1. Germany Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Rheumatic Heart Disease Market

• 18.1. France Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Rheumatic Heart Disease Market

• 19.1. Italy Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Rheumatic Heart Disease Market

• 20.1. Spain Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Rheumatic Heart Disease Market

• 21.1. Eastern Europe Rheumatic Heart Disease Market Overview
• 21.2. Eastern Europe Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Rheumatic Heart Disease Market

• 22.1. Russia Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Rheumatic Heart Disease Market

• 23.1. North America Rheumatic Heart Disease Market Overview
• 23.2. North America Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Rheumatic Heart Disease Market

• 24.1. USA Rheumatic Heart Disease Market Overview
• 24.2. USA Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Rheumatic Heart Disease Market

• 25.1. Canada Rheumatic Heart Disease Market Overview
• 25.2. Canada Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Rheumatic Heart Disease Market

• 26.1. South America Rheumatic Heart Disease Market Overview
• 26.2. South America Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Rheumatic Heart Disease Market

• 27.1. Brazil Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Rheumatic Heart Disease Market

• 28.1. Middle East Rheumatic Heart Disease Market Overview
• 28.2. Middle East Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Rheumatic Heart Disease Market

• 29.1. Africa Rheumatic Heart Disease Market Overview
• 29.2. Africa Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Rheumatic Heart Disease Market Competitive Landscape And Company Profiles

• 30.1. Rheumatic Heart Disease Market Competitive Landscape
• 30.2. Rheumatic Heart Disease Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Rheumatic Heart Disease Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Abbott Laboratories
• 31.3. GlaxoSmithKline plc (GSK)
• 31.4. Medtronic plc
• 31.5. Siemens Healthineers AG
• 31.6. Fresenius Medical Care AG & Co. KGaA
• 31.7. Becton Dickinson and Company (BD)
• 31.8. GE HealthCare Technologies Inc.
• 31.9. Mayo Clinic
• 31.10. Boston Scientific Corporation
• 31.11. Johns Hopkins Medicine
• 31.12. Terumo Corporation
• 31.13. The Mount Sinai Health System Inc.
• 31.14. Apollo Hospitals Enterprise Limited
• 31.15. Fortis Healthcare Limited

32. Global Rheumatic Heart Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Rheumatic Heart Disease Market

34. Recent Developments In The Rheumatic Heart Disease Market

35. Rheumatic Heart Disease Market High Potential Countries, Segments and Strategies

• 35.1 Rheumatic Heart Disease Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Rheumatic Heart Disease Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Rheumatic Heart Disease Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34954_Rheumatic_Heart_Disease_GMR_2025